SARAH KOLCHINSKY: Open Payments
NPI 1174068134 · BRIGHTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$261 in 5 payments from 3 companies in 2025. Trend: 2023 $94 · 2024 $68 · 2025 $261
Food & beverage: $261
| Company | Payments | Amount |
|---|---|---|
| Genmab U.S., Inc. | 1 | $125 |
| Aimmune Therapeutics, Inc. | 1 | $73 |
| PUMA BIOTECHNOLOGY, INC. | 3 | $63 |
Products named: Epkinly, ZENPEP, NERLYNX.
Industry payments across MA — which companies pay providers there.
